These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20709498)

  • 1. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
    Tanaka K; Kato K; Takano T; Katagiri T; Asanoi H; Nejima J; Nakashima M; Kamijo T; Sakanashi M
    J Cardiol; 2010 Nov; 56(3):291-9. PubMed ID: 20709498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of nicorandil therapy in patients with acute heart failure.
    Shirakabe A; Hata N; Yokoyama S; Shinada T; Kobayashi N; Asai K; Mizuno K
    J Cardiol; 2010 Nov; 56(3):339-47. PubMed ID: 20832994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation.
    Minami Y; Nagashima M; Kajimoto K; Shiga T; Hagiwara N
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):335-40. PubMed ID: 19687747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.
    Harada K; Yamamoto T; Okumura T; Shigekiyo M; Terada N; Okada A; Kawata A; Iima T; Harada T; Fujisawa K; Kageyama N; Saito A; Yamamoto H; Fujinaga H
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):329-338. PubMed ID: 26884620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.
    Hattori H; Minami Y; Mizuno M; Yumino D; Hoshi H; Arashi H; Nuki T; Sashida Y; Higashitani M; Serizawa N; Yamada N; Yamaguchi J; Mori F; Shiga T; Hagiwara N
    Heart Vessels; 2013 May; 28(3):345-51. PubMed ID: 22526380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
    Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
    Jain P; Massie BM; Gattis WA; Klein L; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S3-17. PubMed ID: 12594447
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.
    den Uil CA; Lagrand WK; Spronk PE; van der Ent M; Jewbali LS; Brugts JJ; Ince C; Simoons ML
    Eur J Heart Fail; 2009 Apr; 11(4):386-90. PubMed ID: 19211570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.